Security key
65343E207
NextCure, Inc. - Common Stock, $0.001 par value (NXTC)
CUSIP: 65343E207
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.001 par value
- Total 13F shares
- 1,897,561
- Total 13F value
- $26,925,657
- Share change
- +824,352
- SEC-reported price per share
- $14.19
- Number of holders
- 24
- Value change
- +$12,224,139
- Number of buys
- 14
- Number of sells
- 5
- Shares outstanding
- 3,135,972
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
24
Top holders
10
NXTC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
NextCure, Inc. SEC filings
NextCure, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 65343E207
Recent filing periods:
Ownership snapshot
Top reported holders of NXTC - NextCure, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ikarian Capital, LLC
Disclosed value leader
Ikarian Capital, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
3/4/5
13F
Lead comparable stake: 10%
13D/G row: Ikarian Capital, LLC
Showing 1-6 of 15 holder rows.
Quick read
Ikarian Capital, LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ikarian Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Ikarian Capital, LLC
10%
Squadron Capital Management LLC
9.9%
Simcere Zaiming, Inc.
9.4%
Sofinnova Venture Partners IX, L.P.
7.1%
SILVERARC CAPITAL MANAGEMENT, LLC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13D/G
|
10%
|
$4,715,825
363,035 shares
|
$0 | 31 Dec 2025 |
| Squadron Capital Management LLC |
13D/G
Squadron Master Fund LP
|
9.9%
|
$3,521,940
271,127 shares
|
+$1,263,485 | 31 Dec 2025 |
| Simcere Zaiming, Inc. |
13D/G
3/4/5
10%+ Owner
|
9.4%
|
$152,386
338,636 shares
|
$0 | 31 Dec 2025 |
| Sofinnova Venture Partners IX, L.P. |
13D/G
Sofinnova Venture Partners IX, L.P. ("SVP IX")
|
7.1%
|
$2,947,939
222,654 shares
|
$0 | 19 Dec 2025 |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13D/G
|
5%
|
$2,286,980
176,057 shares
|
$0 | 31 Dec 2025 |
| CITIGROUP INC |
13D/G
13F
Citigroup Global Markets Inc. · Company
|
4.3%
|
$506,181
1,205,193 shares
|
$0 | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
24
Shares
1,897,561
Rows available
24
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
16
Q4 2025 holders
24
Holder diff
8
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend